Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMAG Pharma Appoints Pharmacovigilance VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

AMAG Pharma Appoints Pharmacovigilance VP

Johnson to oversee product safety and compliance

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Judith Johnson, M.D., has rejoined AMAG Pharmaceuticals as vice president of pharmacovigilance and pharmacoepidemiology, responsible for all pharmacovigilance functions, including product safety surveillance, aggregate safety reporting, pharmacoepidemiology and risk management. She will also oversee the company’s compliance with FDA and regulatory requirements for Feraheme (ferumoxytol) Injection and MuGard Mucoadhesive Oral Wound Rinse.
 
For the past ten years, Dr. Johnson has held leadership roles in pharmacovigilance and drug safety at companies including EMD Serono, Inc., AMAG, Genzyme and Parexel.  
 
“Judy brings with her a wealth of experience and ability in the areas of drug safety and risk management, which will be critical for the future success of AMAG as we work to build a diversified, multi-product pharmaceutical company,” said Steven Caffe, M.D., senior vice president, chief development and regulatory officer at AMAG

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics